Clinical trials
Phase 1 Vulvar Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2009 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 4 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| HRYZ Biotech Co. | 2 |
| M.D. Anderson Cancer Center | 2 |
| Regeneron Pharmaceuticals | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Beijing Health Guard Biotechnology, Inc | 1 |
| Case Comprehensive Cancer Center | 1 |
| Dana-Farber Cancer Institute | 1 |
| Gene Surgery LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vulvar Neoplasms | 29 |
| Uterine Cervical Neoplasms | 27 |
| Vaginal Neoplasms | 22 |
| Anus Neoplasms | 14 |
| Endometrial Neoplasms | 13 |
| Penile Neoplasms | 12 |
| Carcinoma, Ovarian Epithelial | 11 |
| Fallopian Tube Neoplasms | 11 |
| Breast Neoplasms | 8 |
| Carcinoma, Hepatocellular | 8 |
Trials
Showing 76 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.